Ownership and insider activity for AngioDynamics, Inc. (ANGO): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets.
Price
| Price | $15.46 |
| Market Cap | $639M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $47.5M | $74.1M | $227.6M | $54.4M | $48.2M | $28.8M | $44.6M | $76.1M | $55.9M | $53.9M |
| Short-term Investments | $1.2M | $1.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $46.4M | $39.4M | $43.6M | $34.2M | $37.3M | $56.5M | $52.8M | $50.0M | $43.1M | $48.3M |
| Inventory | $54.5M | $39.3M | $40.1M | $59.9M | $48.6M | $51.4M | $55.3M | $60.6M | $62.0M | $52.4M |
| Total Current Assets | $153.9M | $168.0M | $315.3M | $152.9M | $140.9M | $143.3M | $163.5M | $193.3M | $168.3M | $163.4M |
| Property, Plant & Equipment | $45.2M | $25.7M | $24.3M | $28.3M | $37.1M | $45.0M | $44.4M | $35.7M | $32.3M | $27.1M |
| Goodwill | $361.3M | $361.3M | $347.7M | $201.5M | $201.3M | $201.1M | $159.2M | 0 | 0 | 0 |
| Intangible Assets | $145.7M | $130.3M | $145.4M | $197.1M | $169.0M | $152.4M | $111.1M | $77.4M | $69.1M | $67.2M |
| Total Assets | $708.0M | $705.5M | $836.4M | $595.5M | $561.4M | $552.8M | $532.6M | $317.7M | $280.1M | $267.2M |
| Accounts Payable | $18.1M | $15.8M | $22.8M | $19.1M | $19.6M | $28.0M | $40.4M | $37.8M | $33.3M | $31.5M |
| Short-term Debt | $14.6M | $7.1M | $12.1M | $836000 | 0 | $8.8M | $14.8M | $4.7M | $400000 | 0 |
| Total Current Liabilities | $69.5M | $57.3M | $73.3M | $51.5M | $57.6M | $74.3M | $83.8M | $91.2M | $76.2M | $74.7M |
| Long-term Debt | $91.3M | $86.6M | $124.4M | $40.0M | $20.0M | $25.0M | $49.8M | 0 | $5.8M | 0 |
| Total Liabilities | $190.9M | $162.9M | $221.6M | $139.6M | $122.0M | $128.3M | $154.3M | $112.1M | $97.2M | $96.3M |
| Retained Earnings | -$11.0M | $5.1M | $66.5M | -$100.3M | -$131.9M | -$158.4M | -$210.9M | -$395.2M | -$429.2M | -$465.9M |
| Total Equity | $517.0M | $542.6M | $614.8M | $455.9M | $439.5M | $424.5M | $378.3M | $205.6M | $183.0M | $170.8M |
| Total Debt | $105.9M | $93.7M | $136.5M | $40.8M | $20.0M | $33.8M | $64.6M | $4.7M | $10.1M | 0 |
| Net Debt | $57.2M | $18.3M | -$91.1M | -$13.6M | -$28.2M | $5.0M | $20.0M | -$71.3M | -$45.7M | -$53.9M |
| Working Capital | $84.4M | $110.7M | $242.0M | $101.4M | $83.3M | $69.0M | $79.7M | $102.1M | $92.1M | $88.7M |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 2.19 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 1.48 |
Profitability
| Return on Equity | -21.01% |
| Return on Invested Capital | -20.75% |
| Return on Assets | -13.75% |
| Gross Margin | 54.62% |
| Operating Margin | -12.47% |
| Net Margin | -11.48% |
Related companies: CGEM · FULC · LAB · NMRA · OCGN · OMER · RAPT
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of ANGO: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks